| 2017-12-08 | Sale | Collegium Pharmaceutical, Inc. COLL | 10 percent owner | 2M 6.4738% | $17.34 | $34.68M | +13.11% | |
| 2015-05-12 | Collegium Pharmaceutical, Inc. COLL | 10 percent owner | 400,000 3.1337% | $12.00 | $4.8M | +44.38% | ||
| 2014-11-18 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 10,208 0.0606% | $31.61 | $322,691 | +89.62% | |
| 2014-11-17 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 964,052 6.0879% | $32.79 | $31.61M | +94.47% | |
| 2014-10-09 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 1,886 0.0124% | $30.00 | $56,580 | +121.58% | |
| 2014-10-07 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 23,854 0.1521% | $30.04 | $716,579 | +114.26% | |
| 2013-07-01 | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 433,352 2.8238% | $14.00 | $6.07M | +8.67% |